More recently, the substrate repertoire of AKT has been expanded to include telomeric repeat binding factor 1 (TRF1), a member of the telomere-bound shelterin complex, which is hyperactivated in cancer cells, and endows them with limitless replicative potential [88]. Here, AKT1 is linked to cancer.